JPMorgan downgraded CVRx (CVRX) to Underweight from Neutral with a price target of $7, down from $15. The company reported a miss in Q1 as the planned salesforce reorganization led to greater than expected turnover and account disruption, the analyst tells investors in a research note. The firm says continued uncertainty around potential rate changes in the proposed outpatient prospective payment system come July and “choppiness” in sales growth trends is leading to significant uncertainty around CVRx’s trajectory to cash flow breakeven.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVRX:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue